Specificity and Functionality of MicroRNA Inhibitors

Overview

Journal Silence

Publisher Biomed Central

Date 2010 Apr 3

PMID 20359337

Citations 40

Authors

Barbara Robertson

Andrew B Dalby

Jon Karpilow

Anastasia Khvorova

Devin Leake

Annaleen Vermeulen

Affiliations

Soon will be listed here.

Abstract

Background: Micro(mi)RNAs regulate gene expression through translational attenuation and messenger (m)RNA degradation, and are associated with differentiation, homeostasis and disease. Natural miRNA target recognition is determined primarily by perfect complementarity in a seed region (nucleotide positions 2 to 7) with additional interactions contributing in a sequence- and target-specific manner. Synthetic miRNA target analogs, which are fully complementary, chemically modified oligonucleotides, have been used successfully to inhibit miRNA function.

Results: In this paper, we present a first systematic study to evaluate the effect of mismatches in the target site on synthetic inhibitor activity. Panels of miRNA inhibitors containing two-nucleotide mismatches across the target site were tested against three miRNAs (miR-21, miR-22 and miR-122). The results showed that the function of inhibitors vary as mismatch positions in the inhibitors change.

Conclusions: The data indicate that features important for natural miRNA target recognition (such as seed region complementarity) are also important for inhibitor functionality. In addition, base pairing at a second, more 3' region appears to be equally important in determining the efficacy of synthetic inhibitors. Considering the importance of these inhibitor regions and the expression of closely related miRNA sequences will enable researchers to interpret results more accurately in future experiments.

Citing Articles

Light-regulated microRNAs shape dynamic gene expression in the zebrafish circadian clock.

Wang Z, Wang S, Bi Y, Boiti A, Zhang S, Vallone D PLoS Genet. 2025; 21(1):e1011545.

PMID: 39777894 PMC: 11750094. DOI: 10.1371/journal.pgen.1011545.

Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?.

Thau H, Neuber S, Emmert M, Nazari-Shafti T Cardiol Ther. 2024; 13(1):39-67.

PMID: 38381282 PMC: 10899152. DOI: 10.1007/s40119-024-00353-w.

MicroRNA‑155‑5p affects regulatory T cell activation and immunosuppressive function by targeting BCL10 in myasthenia gravis.

Sun J, Sun M, Li X, Xie Q, Zhang W, Wang M Exp Ther Med. 2024; 27(1):6.

PMID: 38223327 PMC: 10785013. DOI: 10.3892/etm.2023.12293.

Inhibition of microRNA-122 alleviates pyroptosis by targeting dual-specificity phosphatase 4 in myocardial ischemia/reperfusion injury.

Wu H, Fu Q, Li Z, Wei H, Qin S Heliyon. 2023; 9(7):e18238.

PMID: 37539226 PMC: 10393637. DOI: 10.1016/j.heliyon.2023.e18238.

miR-125-3p and miR-276b-3p Regulate the Spermatogenesis of by Targeting the .

Sohail S, Tariq K, Sajid M, Ali M, Peng W, Zhang H Genes (Basel). 2022; 13(10).

PMID: 36292746 PMC: 9601815. DOI: 10.3390/genes13101861.

References

Kim V, Han J, Siomi M . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2):126-39. DOI: 10.1038/nrm2632. View

Krutzfeldt J, Rajewsky N, Braich R, Rajeev K, Tuschl T, Manoharan M . Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005; 438(7068):685-9. DOI: 10.1038/nature04303. View

Lee I, Ajay S, Chen H, Maruyama A, Wang N, McInnis M . Discriminating single-base difference miRNA expressions using microarray Probe Design Guru (ProDeG). Nucleic Acids Res. 2008; 36(5):e27. PMC: 2275156. DOI: 10.1093/nar/gkm1165. View

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

Brennecke J, Stark A, Russell R, Cohen S . Principles of microRNA-target recognition. PLoS Biol. 2005; 3(3):e85. PMC: 1043860. DOI: 10.1371/journal.pbio.0030085. View

Griffiths-Jones S, Grocock R, van Dongen S, Bateman A, Enright A . miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2005; 34(Database issue):D140-4. PMC: 1347474. DOI: 10.1093/nar/gkj112. View

Davis S, Propp S, Freier S, Jones L, Serra M, Kinberger G . Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Res. 2008; 37(1):70-7. PMC: 2615630. DOI: 10.1093/nar/gkn904. View

Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View

Collins M, Irvine B, Tyner D, Fine E, Zayati C, Chang C . A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res. 1997; 25(15):2979-84. PMC: 146852. DOI: 10.1093/nar/25.15.2979. View

10.

Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T . Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell. 2004; 15(2):185-97. DOI: 10.1016/j.molcel.2004.07.007. View

11.

Ibanez-Ventoso C, Vora M, Driscoll M . Sequence relationships among C. elegans, D. melanogaster and human microRNAs highlight the extensive conservation of microRNAs in biology. PLoS One. 2008; 3(7):e2818. PMC: 2486268. DOI: 10.1371/journal.pone.0002818. View

12.

Aleman L, Doench J, Sharp P . Comparison of siRNA-induced off-target RNA and protein effects. RNA. 2007; 13(3):385-95. PMC: 1800510. DOI: 10.1261/rna.352507. View

13.

Kawamata T, Seitz H, Tomari Y . Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol. 2009; 16(9):953-60. DOI: 10.1038/nsmb.1630. View

14.

Castoldi M, Schmidt S, Benes V, Noerholm M, Kulozik A, Hentze M . A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA. 2006; 12(5):913-20. PMC: 1440900. DOI: 10.1261/rna.2332406. View

15.

Grimson A, Farh K, Johnston W, Garrett-Engele P, Lim L, Bartel D . MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007; 27(1):91-105. PMC: 3800283. DOI: 10.1016/j.molcel.2007.06.017. View

16.

Bouasker S, Simard M . Structural biology: Tracing Argonaute binding. Nature. 2009; 461(7265):743-4. DOI: 10.1038/461743a. View

17.

Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z . A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res. 2005; 33(5):1671-7. PMC: 1069010. DOI: 10.1093/nar/gki312. View

18.

Fabani M, Gait M . miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA. 2007; 14(2):336-46. PMC: 2212241. DOI: 10.1261/rna.844108. View

19.

Vermeulen A, Robertson B, Dalby A, Marshall W, Karpilow J, Leake D . Double-stranded regions are essential design components of potent inhibitors of RISC function. RNA. 2007; 13(5):723-30. PMC: 1852807. DOI: 10.1261/rna.448107. View

20.

Griffiths-Jones S . The microRNA Registry. Nucleic Acids Res. 2003; 32(Database issue):D109-11. PMC: 308757. DOI: 10.1093/nar/gkh023. View